This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Watanabe, M. Articles by Sunamori, M. Search for Related Content PubMed PubMed Citation Articles by Watanabe, M. Articles by Sunamori, M. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Coronary Artery Bypass Surgery Social Bookmarking                         What's this?

Differential regulation of MMP-2, TIMP-2 and IL-6 in valve replacement versus CABG patients

Department of Thoracic and Cardiovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan, masa-cvs{at}hiroo-hospital.metro.tokyo.jp

Satoru Hasegawa

Department of Thoracic and Cardiovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan

Nagahisa Ohshima

Department of Thoracic and Cardiovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan

Hiroyuki Tanaka

Department of Thoracic and Cardiovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan

Tohru Sakamoto

Department of Thoracic and Cardiovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan

Makoto Sunamori

Department of Thoracic and Cardiovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan

Background: Extracellular matrix degradation may play an important role in left ventricular (LV) remodeling. It has been reported that matrix metalloproteinase-2 (MMP-2) is activated under mechanical stress conditions. Therefore, we examined the release of MMP-2, its inhibitor and interleukin-6 (IL-6), which affects MMPs, in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB).

Methods: Arterial blood samples were obtained from 20 patients undergoing cardiac surgery and six patients with descending aortic replacement (as noncardiac control) with CPB. Samples were assayed for plasma MMP-2, tissue inhibitors of matrix metalloproteinase-2 (TIMP-2) and IL-6 concentration.

Results: Plasma MMP-2 concentrations in the valvular disease patients were greater than in other patients (p < 0.05) and correlated with the LV mass (r= 0.810, p < 0.0001) prior to the operation. Plasma MMP-2 concentrations decreased during CPB and gradually recovered to the baseline levels after CPB. Plasma TIMP-2 concentrations increased significantly during and after CPB in a biphasic manner. Plasma IL-6 concentrations also increased significantly during CPB (p < 0.05 versus baseline levels).

Conclusion: Plasma MMP-2 concentrations reflect the state of the left ventricle, and changes in plasma MMP-2 and TIMP-2 concentrations during CPB may play an important role in LV remodeling after cardiac surgery.

Perfusion, Vol. 17, No. 6, 435-439 (2002)
DOI: 10.1191/0267659102pf612oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				W. Eichler, J F M. Bechtel, J. Schumacher, J. A Wermelt, K.-F. Klotz, and C. Bartels A rise of MMP-2 and MMP-9 in bronchoalveolar lavage fluid is associated with acute lung injury after cardiopulmonary bypass in a swine model Perfusion, March 1, 2003; 18(2): 107 - 113. [Abstract] [PDF]